Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review provides an overview of skin manifestations associated with substance use disorder but reports no new clinical findings; the authors emphasize the importance of dermatological evaluation and multidisciplinary care in managing these cases.

This study presents four cases of delusions of parasitosis and introduces escitalopram as a potential therapy, highlighting its fewer side effects compared to the commonly used pimozide.

This review discusses common psychodermatologic conditions and provides practical diagnostic and therapeutic recommendations but reports no new results; the authors emphasize the challenge of treating patients who lack insight into their psychiatric symptoms.

This source highlights the emerging field of psychodermatology, which examines the interplay between psychological factors and skin disorders, noting a historical lack of attention due to inadequate professional training and emphasizing the need for integrated care involving dermatologists, psychiatrists, and psychologists.

This study reports that over one-quarter of dermatology outpatients show psychiatric morbidity, highlighting the importance of considering psychological factors in managing skin diseases.

This review provides practical guidelines for managing psychodermatologic disorders and concludes that psychopharmacologic agents offer a useful option for treatment, considering the underlying psychopathologic condition.

This article reviews milestones in understanding psychosomatic factors in dermatology and outlines clinical criteria for identifying them, but it presents no new research data.

This review discusses psychocutaneous syndromes, detailing their classifications and management strategies, but reports no new clinical findings; it underscores dermatologists' role in these cases.

This paper reviews the growing use of psychotropic drugs in dermatology due to the link between mental states and skin conditions but does not present new clinical findings.

This article reviews the interconnectedness of the skin and nervous system and discusses various treatment options for psychophysiological skin disorders, reporting no new clinical results.

This article reviews the development and theories of psychosomatic concepts in dermatology, outlining classifications of psychocutaneous disease and suggesting improvements in clinical practice, without reporting new research results.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

This review discusses psychocutaneous disorders in children with an emphasis on primary psychiatric disorders manifesting through skin symptoms, but provides no new clinical findings.

This review discusses the importance of recognizing and treating psychiatric conditions in dermatology patients, offering practical recommendations for dermatologists to manage psychocutaneous diseases effectively, but reports no new clinical results.

The current state and future directions of the field that studies the connection between the mind and skin are discussed.

This study proposed a detailed classification of psychodermatosis by examining three cases that illustrate the interaction between the brain and skin, resulting in conditions like trichotillomania and factitious dermatitis.

This review discusses the relationship between stress and skin disorders, highlighting psychodermatoses and recommending mind-body techniques and collaborative care involving dermatology, psychiatry, and psychology, without reporting new clinical results.

This report discusses the complex interplay between dermatological and psychiatric conditions and presents insights shared at the 22nd EADV Congress, but it reports no new research results.

This review presents possible classifications of psychological disorders that significantly impact dermatology, along with their clinical characteristics and comorbidities, highlighting lesions as potential warning signs based on DSM-5 and ICD-10 codes.

In this study, researchers highlighted the complexity of managing psychocutaneous disorders, emphasizing the need for a multidisciplinary approach involving dermatologists, psychiatrists, family physicians, and social support to address associated psychiatric diagnoses, risk factors like suicide, and ensure effective treatment.

This article argues that psychoactive drugs are often beneficial in treating dermatological conditions with psychiatric or psycho-emotional components but does not present new clinical evidence.

This review provides updated information on primary psychiatric disorders with skin manifestations, highlighting a 30% psychiatric comorbidity prevalence in dermatology outpatients, but it reports no new research findings.

This study, involving an international panel of 16 psychodermatology experts, proposed a new classification system for psychodermatology disorders that aims to unify previous classifications and improve their management by systematizing disorders into two main categories: primary mental health disorders and primary skin disorders.

This article reviews the psychiatric conditions associated with HIV, highlighting the bidirectional relationship and management challenges but presents no new research findings.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

This study found that children and adolescents with dermatological disorders had significantly higher rates of psychiatric comorbidity, including mood and anxiety disorders, compared to healthy controls.

This review explores psychodermatology and platelet-rich plasma as complementary approaches for enhancing patient-centered care in dermatology, reporting no new results but highlighting their potential to improve outcomes and quality of life.

This article describes the Frontiers journal series, highlighting its open-access approach and tiered publishing system, but it presents no new empirical findings.

This review discusses the interplay between dermatology and psychology in psychodermatology, highlighting the impact of neuroendocrine stress pathways on skin diseases and the importance of considering skin of color.

This review discusses the challenges of diagnosing and managing somatization in dermatology patients, highlighting the need for comprehensive evaluation of unexplained dermatologic symptoms, and reports no new results.